CCM
TCRT icon

Chiron Capital Management’s Alaunos Therapeutics TCRT Stock Holding History

Chiron Capital Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-448
Closed -$4.75K – 120
2023
Q4 		$4.75K Sell
448
-65
-13% -$783 ﹤0.01% 117
2023
Q3 		$10.2K Sell
513
-18
-3% -$775 0.01% 112
2023
Q2 		$40.6K Sell
531
-15
-3% -$1.21K 0.03% 113
2023
Q1 		$51.6K Sell
546
-160
-23% -$15.2K 0.04% 121
2022
Q4 		$68.7K Sell
706
-73
-9% -$10.6K 0.05% 122
2022
Q3 		$201K Sell
779
-51
-6% -$14.8K 0.14% 107
2022
Q2 		$154K Sell
830
-136
-14% -$13K 0.1% 117
2022
Q1 		$95K Buy
966
+171
+22% +$21.9K 0.06% 121
2021
Q4 		$130K Sell
795
-525
-40% -$115K 0.09% 106
2021
Q3 		$360K Sell
1,320
-20
-1% -$6.12K 0.26% 70
2021
Q2 		$531K Buy
1,340
+8
+0.6% +$3.73K 0.44% 48
2021
Q1 		$719K Sell
1,332
-8
-0.6% -$4.98K 0.61% 31
2020
Q4 		$507K Sell
1,340
-3
-0.2% -$1.19K 0.42% 45
2020
Q3 		$508K Buy
+1,343
New +$593K 0.41% 39

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Chiron Capital Management's TCRT Position: Q1 2024 in Review

Chiron Capital Management sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 448 shares — an estimated $4.75K sold.

Chiron Capital Management first reported a position in TCRT in Q3 2020 and held it in 14 quarters. The position peaked at $719K in Q1 2021. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.

  • Chiron Capital Management reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Chiron Capital Management sold 448 Alaunos Therapeutics shares in Q1 2024, an estimated $4.75K.
  • Chiron Capital Management first reported a position in Alaunos Therapeutics in Q3 2020 and held it in 14 quarters.
  • Chiron Capital Management's Alaunos Therapeutics position peaked at $719K in Q1 2021.
  • 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.

Based on Chiron Capital Management's 13F filing for Q1 2024, filed 10 May 2024.